✦ LIBER ✦

P-201 First-line chemotherapy with gemzar® (gemcitabine, GEM) and cisplatin (CIs) in Asian patients with advanced non-small cell lung cancer (NSCLC) — A prospective observational study

✍ Scribed by Kim, Sun Young; Sudershan, Gambhir; Villalon, Antonio H.; Shaharyar, Shaharyar; Vu, Vu V.; Park, Jae Yong; John, Subhashini; Jung, Maan-Hong; Lehnert, Manfred

Book ID: 118571902
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 162 KB
Volume: 41
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(03)92170-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Non-cisplatin-based chemotherapy for adv

Non-cisplatin-based chemotherapy for advanced non-small cell lung cancer (NSCLC). A phase II study with vinorelbine (VNR) and gemcitabine (GEM)

✍ Rodríguez, R; Fírvada, JL; Mel, JR; Castellanos, J; Salgado, M; Mata, JG; Quinte 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 129 KB

Cisplatin and vinorelbine as second-line

Cisplatin and vinorelbine as second-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) resistant to taxol plus gemcitabine

✍ De Pas, Tommaso; de Braud, Filippo; Mandalà, Mario; Curigliano, Giuseppe; Catani 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 55 KB

32 Single-agent Gemzar® (Gemcitabine, GE

32 Single-agent Gemzar® (Gemcitabine, GEM) versus cisplatin plus etoposide (CE): A randomized phase II study in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC)

✍ Manegold, Ch.; Stahel, R.; Mattson, K.; Ricci, S.; van Walree, N.C.; Bergman, B. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 131 KB

Vinorelbine, ifosfamide and cisplatin (N

Vinorelbine, ifosfamide and cisplatin (NIP) as first line chemotherapy in patients with non-small-cell lung cancer (NSCLC)

✍ Teixeira, E; Sotto-Mayor, R; Borges, M; Bugalho de Almeida, A 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 104 KB

Combination chemotherapy with carboplati

Combination chemotherapy with carboplatin (CBDCA), docetaxel (DOC) and gemcitabine (GEM) in advanced non-small cell lung cancer (NSCLC). A phase II study

✍ Pectasides, D.; Aspropotamitis, A.; Halikia, A.; Visvikis, A.; Antoniou, F.; Kal 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 165 KB

1310 POSTER A phase II study with cispla

1310 POSTER A phase II study with cisplatin (cddp) and gemcitabine (gem) in elderly patients with advanced non-small cell lung cancer

✍ L. Buffoni; D. Dongiovanni; C. Barone; E. Larovere; R. Grillo; F. Gaspari; M. Sc 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 79 KB